ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ADVFN Morning London Market Report: Tuesday 12 December 2017

Share On Facebook
share on Linkedin
Print

London open: Stocks nudge up as investors eye inflation data; Ashtead rallies

© ADVFN

London stocks nudged higher in early trade on Tuesday as investors eyed the release of key UK inflation data.

At 0830 GMT, the FTSE 100 was up 0.1% to 7,458.99, while the pound was flat against the euro at 1.1338 and 0.1% firmer against the dollar at 1.3360.

The Office for National Statistics will publish the latest consumer price index, retail price index and producer price index at 0930 GMT.

Spreadex analyst Connor Campbell said: “November’s CPI reading is expected to remain unchanged at 3.0% for the third month in a row, potentially allaying fears – in part prompted by certain actions taken by the Bank of England – that the figure would keep climbing across the final quarter of the year.

“It’ll be interesting to see how sterling reacts to such steadiness: on one hand if the inflation data does stay the same, then there’s little chance of the BoE changing its dovish-ish stance any time soon; on the other, a sign that things might be easing for UK consumer heading into Christmas would be welcome.”

In corporate news, industrial equipment rental firm Ashtead rallied after it posted a 16% rise in half-year pre-tax profits to £493.1m and announced the start of a share buyback programme, of at least £500m and up to £1bn over the next 18 months.

Construction group Balfour Beatty was trading up after saying it is “increasingly confident” of improving margins this year as it continues to win new business on better terms.

GlaxoSmithKline was higher after saying it has presented promising new data from the dose expansion phase of a study of an investigational anti-B-cell antibody-drug conjugate to treat cancer.

Aggreko nudged up after giving a timeline to the appointment of its new chief financial officer, confirming that Heath Drewett would take up the role on 3 January.

Power generator Drax slipped after it said trading conditions remained in line with expectations since interim results reported on July 19.

Experian was boosted by an upgrade to ‘outperform’ at Exane, while Homeserve gained as JPMorgan Cazenove lifted the stock to ‘overweight’ and Grainger was up on the back of an initiation at ‘overweight’ by Barclays.

EasyJet flew higher following an upgrade to ‘outperform’ at Davy, but Mediclinic and Moneysupermarket were hit by downgrades from JPMorgan Cazenove, while Capital & Counties was weaker as Barclays initiated coverage of the stock at ‘underweight’.

Pub group Greene King was under the cosh after a downgrade to ‘underweight’ from JPMorgan, with Marston’s following suit.

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Plc. ADVFN Plc does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.

Leave A Reply

 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com